Trial reportEndocrine2022
Making sense of diabetes medication decisions: a mixed methods cluster randomized trial using a conversation aid intervention.
Trial report in Endocrine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Translating Information on Comparative Effectiveness Into Practice (TRICEP)
Translation of Comparative Effectiveness of Depression Medications Into Practice
Who cites it
13 citing papers in PubMed, 6 syntheses or guidelines pooled it, 28 citations in OpenAlex.
- Consultation-based interventions to optimize medication adherence in primary care: a systematic review.Family practice · 2026Pooled it
- Mapping research trends in shared decision-making for type 2 diabetes mellitus: a bibliometric study.Frontiers in health services · 2026Pooled it
- To what extent do general practitioners involve patients in decision-making? A systematic review of studies using the OPTION-instrument.Primary health care research & development · 2025Pooled it
- A systematic review of shared decision making training programs for general practitioners.BMC medical education · 2024Pooled it
- Shared Decision-Making in Cardiovascular Risk Factor Management: A Systematic Review and Meta-Analysis.JAMA network open · 2024Pooled it
- Pooled it
- Shared Decision-Making for Patients Hospitalized with Acute Myocardial Infarction: A Randomized Trial.Patient preference and adherence · 2022Trial
- Exploring the Needs of Health Professionals for a Type 2 Diabetes Remote Patient Monitoring Dashboard for Personalized Care: Focus Group Study.JMIR diabetes · 2026Article
- A Quantitative Study Exploring and Comparing Key Factors in Medication Management in the Irish Healthcare Setting.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Patient Characteristics and the Extent to Which Clinicians Involve Patients in Decision Making: Secondary Analyses of Pooled Data.Medical decision making : an international journal of the Society for Medical Decision Making · 2024Article
- Patient Participation in Medication Safety for Noncommunicable Diseases: A Qualitative Study of General Practitioners, Pharmacists, and Outpatients' Perspectives in Beijing.Patient preference and adherence · 2024Article
- Problem-based shared decision-making in diabetes care: a secondary analysis of video-recorded encounters.BMJ evidence-based medicine · 2023Article
- Problem-based shared decision making: The role of canonical SDM steps.Health expectations : an international journal of public participation in health care and health policy · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
26 authors at 11 institutions in 5 countries.
Funding
Abstract
purposeTo determine the effectiveness of a shared decision-making (SDM) tool versus guideline-informed usual care in translating evidence into primary care, and to explore how use of the tool changed patient perspectives about diabetes medication decision making.
methodsIn this mixed methods multicenter cluster randomized trial, we included patients with type 2 diabetes mellitus and their primary care clinicians. We compared usual care with or without a within-encounter SDM conversation aid. We assessed participant-reported decisions made and quality of SDM (knowledge, satisfaction, and decisional conflict), clinical outcomes, adherence, and observer-based patient involvement in decision-making (OPTION12-scale). We used semi-structured interviews with patients to understand their perspectives.
resultsWe enrolled 350 patients and 99 clinicians from 20 practices and interviewed 26 patients. Use of the conversation aid increased post-encounter patient knowledge (correct answers, 52% vs. 45%, p = 0.02) and clinician involvement of patients (Mean between-arm difference in OPTION12, 7.3 (95% CI 3, 12); p = 0.003). There were no between-arm differences in treatment choice, patient or clinician satisfaction, encounter length, medication adherence, or glycemic control. Qualitative analyses highlighted differences in how clinicians involved patients in decision making, with intervention patients noting how clinicians guided them through conversations using factors important to them.
conclusionsUsing an SDM conversation aid improved patient knowledge and involvement in SDM without impacting treatment choice, encounter length, medication adherence or improved diabetes control in patients with type 2 diabetes. Future interventions may need to focus specifically on patients with signs of poor treatment fit. CLINICAL
trial registrationClinicalTrial.gov: NCT01502891.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.